Tech Company Financing Transactions

XLumena Funding Round

On 4/29/2011, XLumena announced $7 million in Series B funding from Aperture Venture Partners, Ascent Biomedical Ventures and CLS.

Transaction Overview

Company Name
Announced On
4/29/2011
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors

Aperture Venture Partners (Lead Investor) (Eric Sillman)

Ascent Biomedical Ventures (Avi Kometz)

CLS (Barr Dolan)

Prism VentureWorks (Tony Natale)

Western Technology Investment

Proceeds Purpose
This financing will support our market introductions in the US and Europe.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
453 Ravendale Dr. H
Mountain View, CA 94043
USA
Email Address
Overview
Xlumena is the leader in the developments of image-guided therapeutic endoscopy products specializing in advanced implants and devices that address multiple markets. Collaborating with top physicians in the field, Xlumena focuses on technology that advances therapy to the next level.
Profile
XLumena LinkedIn Company Profile
Social Media
XLumena Company Twitter Account
Company News
XLumena News
Facebook
XLumena on Facebook
YouTube
XLumena on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Greg Patterson
  Greg Patterson LinkedIn Profile  Greg Patterson Twitter Account  Greg Patterson News  Greg Patterson on Facebook
Chief Medical Officer
Kenneth Binmoeller
  Kenneth Binmoeller LinkedIn Profile  Kenneth Binmoeller Twitter Account  Kenneth Binmoeller News  Kenneth Binmoeller on Facebook
VP - Operations
Mark Scratch
  Mark Scratch LinkedIn Profile  Mark Scratch Twitter Account  Mark Scratch News  Mark Scratch on Facebook
VP - R & D
Peter Brown
  Peter Brown LinkedIn Profile  Peter Brown Twitter Account  Peter Brown News  Peter Brown on Facebook
VP - Regulatory Affairs
Jane Beggs
  Jane Beggs LinkedIn Profile  Jane Beggs Twitter Account  Jane Beggs News  Jane Beggs on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/28/2011: Invoke Solutions venture capital transaction
Next: 4/29/2011: OptMed venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary